Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume N/A
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts N/A
Price Target N/A

Company Profile

The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Phone: 888-658-8287
BillionerOfKing
BillionerOfKing Feb. 22 at 5:27 PM
$BBH Current Stock Price: $197.25 Contracts to trade: $195.0 BBH Mar 20 2026 Call Entry: $4.50 Exit: $6.41 ROI: 43% Hold ~30 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
SuperGreenToday
SuperGreenToday Feb. 22 at 2:26 PM
$BBH Share Price: $197.25 Contract Selected: Sep 18, 2026 $210 Calls Buy Zone: $5.95 – $7.35 Target Zone: $11.24 – $13.74 Potential Upside: 78% ROI Time to Expiration: 207 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 11 at 1:01 PM
$BBH RSI: 44.89, MACD: 1.1478 Vol: 3.27, MA20: 196.08, MA50: 193.57 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
StocktwitsNews
StocktwitsNews Feb. 10 at 12:36 PM
PLRZ Stock Jumps 6% In Pre-Market – Why Is This Biotech Firm Diversifying Into Aviation Business? $PLRZ $BBH $IBB https://stocktwits.com/news/equity/markets/why-did-plrz-stock-gain-premarket/cZbU3zNR4Yr
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 10 at 2:31 AM
$BBH Current Stock Price: $198.18 Contracts to trade: $195.0 BBH Feb 20 2026 Call Entry: $3.00 Exit: $5.67 ROI: 89% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
StocktwitsNews
StocktwitsNews Jan. 30 at 1:16 PM
Regeneron’s New Growth Engine Is Starting To Show – But Core Eylea Weakness Weighs On REGN Stock $REGN $BBH $IBB $THNR https://stocktwits.com/news/equity/markets/regn-stock-slips-regeneron-earnings-q4-eylea-hd-revenue/cmySjWfR4S5
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 24 at 6:47 PM
$BBH Share Price: $197.52 Contract Selected: Jun 18, 2026 $200 Calls Buy Zone: $7.22 – $8.93 Target Zone: $12.67 – $15.49 Potential Upside: 66% ROI Time to Expiration: 144 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
rachelstocks
rachelstocks Jan. 3 at 3:34 PM
$AMGN $BBH $REGN $SPY $VRTX 👀 good stuff
1 · Reply
eWhispers
eWhispers Jan. 3 at 3:08 PM
83% of Biotech stocks in $BBH have outperformed the S&P 500 $SPY over the past quarter, yet it remains when of the most disliked groups. In fact, sentiment remains near Liberation Day lows. You'll have to wait until February to get a look at their fourth quarter earnings, but that's a lot of time to drift. https://www.earningswhispers.com/wrs $REGN $VRTX $AMGN
0 · Reply
LogicLuster
LogicLuster Dec. 27 at 12:38 PM
$BBH Valuation sensitivity is high because visibility is uneven; pipeline visibility needs clearer corroboration — improving transparency could compress perceived risk. Until validation appears, volatility remains the default.
0 · Reply
Latest News on BBH
BBH: Mature Biotech Exposure, But Limited Growth Ahead

Jan 21, 2026, 4:26 PM EST - 4 weeks ago

BBH: Mature Biotech Exposure, But Limited Growth Ahead


BBH: Fear Of Price Controls Is Not The Problem

May 14, 2025, 9:00 AM EDT - 10 months ago

BBH: Fear Of Price Controls Is Not The Problem


BBH: Buy Rating, As Tech Investors Look Beyond FAANG

Jul 23, 2024, 5:12 AM EDT - 1 year ago

BBH: Buy Rating, As Tech Investors Look Beyond FAANG


Why Biotech Stocks May Be Ready For A Recovery

Mar 9, 2024, 3:59 AM EST - 2 years ago

Why Biotech Stocks May Be Ready For A Recovery

IBB XLV


BBH: A Solid Way To Play A Comeback In Biotech

Dec 9, 2023, 11:08 AM EST - 2 years ago

BBH: A Solid Way To Play A Comeback In Biotech


BBH: Our Favorite Biotech ETF Can Keep Outperforming

Sep 13, 2023, 3:08 AM EDT - 2 years ago

BBH: Our Favorite Biotech ETF Can Keep Outperforming


BBH: A Solid Choice For Biotech Exposure

May 27, 2023, 5:44 AM EDT - 2 years ago

BBH: A Solid Choice For Biotech Exposure


Can Health Care Stocks Outperform Again In 2023?

Jan 11, 2023, 6:09 PM EST - 3 years ago

Can Health Care Stocks Outperform Again In 2023?

AGNG ARKG BBC BBP BMED CNCR FBT


BillionerOfKing
BillionerOfKing Feb. 22 at 5:27 PM
$BBH Current Stock Price: $197.25 Contracts to trade: $195.0 BBH Mar 20 2026 Call Entry: $4.50 Exit: $6.41 ROI: 43% Hold ~30 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
SuperGreenToday
SuperGreenToday Feb. 22 at 2:26 PM
$BBH Share Price: $197.25 Contract Selected: Sep 18, 2026 $210 Calls Buy Zone: $5.95 – $7.35 Target Zone: $11.24 – $13.74 Potential Upside: 78% ROI Time to Expiration: 207 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 11 at 1:01 PM
$BBH RSI: 44.89, MACD: 1.1478 Vol: 3.27, MA20: 196.08, MA50: 193.57 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
StocktwitsNews
StocktwitsNews Feb. 10 at 12:36 PM
PLRZ Stock Jumps 6% In Pre-Market – Why Is This Biotech Firm Diversifying Into Aviation Business? $PLRZ $BBH $IBB https://stocktwits.com/news/equity/markets/why-did-plrz-stock-gain-premarket/cZbU3zNR4Yr
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 10 at 2:31 AM
$BBH Current Stock Price: $198.18 Contracts to trade: $195.0 BBH Feb 20 2026 Call Entry: $3.00 Exit: $5.67 ROI: 89% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
StocktwitsNews
StocktwitsNews Jan. 30 at 1:16 PM
Regeneron’s New Growth Engine Is Starting To Show – But Core Eylea Weakness Weighs On REGN Stock $REGN $BBH $IBB $THNR https://stocktwits.com/news/equity/markets/regn-stock-slips-regeneron-earnings-q4-eylea-hd-revenue/cmySjWfR4S5
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 24 at 6:47 PM
$BBH Share Price: $197.52 Contract Selected: Jun 18, 2026 $200 Calls Buy Zone: $7.22 – $8.93 Target Zone: $12.67 – $15.49 Potential Upside: 66% ROI Time to Expiration: 144 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
rachelstocks
rachelstocks Jan. 3 at 3:34 PM
$AMGN $BBH $REGN $SPY $VRTX 👀 good stuff
1 · Reply
eWhispers
eWhispers Jan. 3 at 3:08 PM
83% of Biotech stocks in $BBH have outperformed the S&P 500 $SPY over the past quarter, yet it remains when of the most disliked groups. In fact, sentiment remains near Liberation Day lows. You'll have to wait until February to get a look at their fourth quarter earnings, but that's a lot of time to drift. https://www.earningswhispers.com/wrs $REGN $VRTX $AMGN
0 · Reply
LogicLuster
LogicLuster Dec. 27 at 12:38 PM
$BBH Valuation sensitivity is high because visibility is uneven; pipeline visibility needs clearer corroboration — improving transparency could compress perceived risk. Until validation appears, volatility remains the default.
0 · Reply
BigBlocKBuyer
BigBlocKBuyer Nov. 11 at 5:57 PM
$IWM $BBH noticing significant rotation into Heavy weighted Russell 2000 small cap biotechs today. Does this rotation help the small cap rally or just a one day blip?
0 · Reply
Friendlyfox
Friendlyfox Nov. 2 at 1:45 AM
0 · Reply
PineGate
PineGate Oct. 8 at 7:36 PM
$XBI $BBH $REGN $MRNA Calling the pancreatic program “high risk” ignores the latest data: the lead blood-based biomarker panel just posted 100% sensitivity / 95% specificity in feasibility and detected precancerous lesions. Next steps are already mapped: larger retrospective cohort (NGS to lock the panel) to PCR-based validation for scale (lower cost, fast TAT, ubiquitous lab hardware). That’s textbook de-risking from signal and product path, not hype
0 · Reply
Thamb19
Thamb19 Oct. 1 at 1:32 AM
$BMRN $GNOM $BBH $IBB Biomarin calls indicate max pain can shift to $60 with a 15% upside. Check out max pain...
0 · Reply
Thamb19
Thamb19 Oct. 1 at 1:30 AM
$BMRN $BBH $IBB $GNOM Biomarin darkpool activity and algos bought and price held. Check my posts below.
0 · Reply
SemiRetiredBlueCollarGuy
SemiRetiredBlueCollarGuy Aug. 31 at 5:52 AM
Five Best Health Sector ETFs to Own Long-Term 1. $IHI - iShares U.S. Medical Devices ETF 2. $BBH - Virtus LifeSci Biotech Products ETF 3. $VHT - Vanguard Health Care ETF 4. $XLV - The Health Care Select Sector SPDR® Fund 5. $FHLC - Fidelity MSCI Health Care Index ETF
0 · Reply
SemiRetiredBlueCollarGuy
SemiRetiredBlueCollarGuy Aug. 31 at 5:51 AM
5 Best Health Sector ETFs to Own Long Term 1. $IHI - iShares U.S. Medical Devices ETF 2. $BBH - Virtus LifeSci Biotech Products ETF 3. $VHT - Vanguard Health Care ETF 4. $XLV - The Health Care Select Sector SPDR® Fund 5. $FHLC - Fidelity MSCI Health Care Index ETF
0 · Reply
TalkMarkets
TalkMarkets Aug. 8 at 5:42 AM
BBH: A Biotech Fund That's Ripe For A Major Turnaround $BBH $XBI $SPX https://talkmarkets.com/content/etfs/bbh-a-biotech-fund-thats-ripe-for-a-major-turnaround?post=514117
0 · Reply
eWhispers
eWhispers May. 10 at 1:03 PM
Every single Biotech stock in $BBH is lagging the S&P 500 $SPY since reporting earnings... FYI. https://www.earningswhispers.com/wrs $MRNA $BNTX $RGEN
1 · Reply